-

Global Fixed Asset Management (FMA) Software Market Report 2022-2026: Market is Poised to Grow by $2.65 Billion - Growing Adoption of Cloud-based Deployment Solutions - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Fixed Asset Management Software Market 2022-2026" report has been added to ResearchAndMarkets.com's offering.

The fixed asset management software market is poised to grow by $2.65 bn during 2022-2026, progressing at a CAGR of 11.32%

This study identifies the growing fixed asset management software launches as one of the prime reasons driving the fixed asset management software market growth during the next few years. The market is driven by the growing adoption of cloud-based deployment solutions and the increasing demand for improved fixed asset management software.

The report on the fixed asset management software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The fixed asset management software market analysis includes the deployment segment and geographic landscape.

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading fixed asset management software market vendors that include AccuFund Inc., Acumatica Inc., Bloomberg LP, EAZY ERP, Infor Inc., International Business Machines Corp., Multiview Corp., Oracle Corp., Sage Group Plc, and SAP SE.

Also, the fixed asset management software market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Key Topics Covered:

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2021
  • Market outlook: Forecast for 2021 - 2026

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Deployment

  • Market segments
  • Comparison by Deployment
  • On-premise - Market size and forecast 2021-2026
  • Cloud - Market size and forecast 2021-2026
  • Market opportunity by Deployment

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2021-2026
  • Europe - Market size and forecast 2021-2026
  • APAC - Market size and forecast 2021-2026
  • MEA - Market size and forecast 2021-2026
  • South America - Market size and forecast 2021-2026
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AccuFund Inc.
  • Acumatica Inc.
  • Bloomberg LP
  • EAZY ERP
  • Infor Inc.
  • International Business Machines Corp.
  • Multiview Corp.
  • Oracle Corp.
  • Sage Group Plc
  • SAP SE

For more information about this report visit https://www.researchandmarkets.com/r/asqu76

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom